Latest News

• share
• favorite_border

Minute Maid Park Event honors Anne, John Mendelsohn in tribute to Texas’ diverse culture.

• share
• favorite_border

Spring is in bloom at The University of Texas MD Anderson Cancer Center Children's Art Project (CAP). Its new product collection is filled with bright, creative and seasonal designs developed by pediatric and adolescent cancer patients.

• share
• favorite_border

Not all diet plans help reduce a person’s chances of developing cancer. Nutrition experts from MD Anderson separate the good from the bad among popular diets.

• share
• favorite_border

The 14th annual Sprint for Life 5K Run/Walk and Sprint for Sprouts Kids' Run, benefiting the Blanton-Davis Ovarian Cancer Research Program at The University of Texas MD Anderson Cancer Center, will be held Saturday, May 7 in the Texas Medical Center.

• share
• favorite_border

Everything is bigger in Texas, and the annual Polo on the Prairie fundraiser is celebrating 25 years in a big way. Grammy®-nominated recording artist Pat Green is the performer at this year's event, slated for April 30 at the Mussleman Brothers' Lazy 3 Ranch in Albany, Texas. Proceeds will benefit cancer research and patient care programs at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Two sets of gene expression profiles predict response to a common lung cancer drug for patients that have no guiding indicators for their treatment now, scientists from The University of Texas MD Anderson Cancer Center report at the AACR 102nd Annual Meeting.

• share
• favorite_border

A common genetic variation links to both bladder cancer risk and to the length of protective caps found on the ends of chromosomes, scientists at The University of Texas MD Anderson Cancer Center reported today at the AACR 102nd Annual Meeting.

• share
• favorite_border

High-density lipoprotein's hauls excess cholesterol to the liver for disposal, but new research suggests "good cholesterol" can also act as a special delivery vehicle of destruction for cancer.

• share
• favorite_border

The Council for Advancement and Support of Education (CASE) District IV has named Michael C. Frick, associate vice president for development at The University of Texas MD Anderson Cancer Center, the recipient of its 2011 Distinguished Achievement Award.

• share
• favorite_border

Noted hematologist Edward J. Benz Jr., M.D., is the 2011 recipient of the Margaret L. Kripke Legend Award for Promotion of Women in Cancer Medicine and Cancer Science presented by The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Renato Lenzi, M.D., medical oncologist at The University of Texas MD Anderson Cancer Center and colon cancer survivor, knows only too well how important preventive methods are to beating colorectal cancer. After all, a routine colonoscopy saved his life.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center has been awarded a grant to study whether xerostomia, a debilitating side effect caused by head and neck cancer radiation treatment, can be prevented when acupuncture is part of a patient's treatment regimen.

• share
• favorite_border

Polo and Pat Green: It's a winning combination, and all for a great cause. World-class polo players and The University of Texas MD Anderson Cancer Center supporters are gearing up for Polo on the Prairie's 25th anniversary, April 30 at the Musselman Brothers' Lazy 3 Ranch in Albany, Texas. Proceeds will benefit cancer research and patient care programs at MD Anderson.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center today signed a sister institution agreement with the National Cancer Institute of Peru. Also known as the Instituto Nacional de Enfermedades Neoplásicas, INEN is Peru's sole national referral center for cancer. The agreement was signed during a ceremony at the Palacio de Gobierno presidential palace in Lima.

• share
• favorite_border

Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.

• share
• favorite_border

Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.

• share
• favorite_border

MD Anderson recommends ways to get a more affordable colonoscopy.

• share
• favorite_border

Like a bounty hunter returning escapees to custody, a cancer-fighting gene converts organ cells that change into highly mobile stem cells back to their original, stationary state, researchers report online at Nature Cell Biology.

• share
• favorite_border

While studying one tumor-suppressing protein, Cheryl Walker's research team at The University of Texas MD Anderson Cancer Center came across a separate surprise. They found another protective protein known to work inside the cell nucleus moonlighting out in the cell's cytoplasm.

• share
• favorite_border

The American Society for Blood and Marrow Transplantation has honored leader, innovator and educator Richard Champlin, M.D., with its Lifetime Achievement Award during the group's annual meeting Feb. 17-21.

• share
• favorite_border

An essential protein for normal stem cell renewal also promotes the growth of breast cancer stem cells when it's overproduced in those cells, researchers at The University of Texas MD Anderson Cancer Center reported in Cancer Cell.

• share
• favorite_border

MD Anderson encourages everyone to get 30 minutes of daily exercise.

• share
• favorite_border

In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine tumors (pNET), according to researchers from The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

A $4 million, five-year grant from the National Cancer Institute will create a Texas regional Community Networks Program Center (CNPC), called Latinos Contra El Cancer, to reduce cancer-related health disparities among Texas Latinos.

• share
• favorite_border

A targeted delivery combination selectively crosses the tight barrier that protects the brain from the bloodstream to home in on and bind to brain tumors, a research team led by scientists from The University of Texas MD Anderson Cancer Center reported in the January issue of the Journal of Clinical Investigation.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center's popular web-based teen prevention and smoking-cessation program, ASPIRE (A Smoking Prevention Interactive Experience), now speaks Spanish.

• share
• favorite_border

Practicing stress management techniques before prostate cancer surgery may help activate the body's immune response leading to quicker recovery, as well as aid in lowering mood disturbance, according to a new study by researchers at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

The Khalifa bin Zayed Al Nahyan Charity Foundation is granting $150 million to The University of Texas MD Anderson Cancer Center to support genetic-analysis based research, diagnosis and treatment of cancer.

• share
• favorite_border

MD Anderson experts share age-specific cancer prevention tips for women.

• share
• favorite_border

Researchers demonstrate that miR-34a targets the CD44 surface protein, which is common on cancer stem cells, to inhibit formation of cells thought to drive the disease. CD44 is associated with tumor development, progression and metastasis.

• share
• favorite_border

Innovative insights into a vital tumor-suppressing mechanism that is often broken in malignant cells and a type of receptor protein that frequently goes haywire to stimulate cancer growth have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a distinguished association of scholars.

• share
• favorite_border

The interplay between a major tumor-suppressing gene, a truncated chromosome and two sets of microRNAs provides a molecular basis for explaining the less aggressive form of chronic lymphocytic leukemia, an international team of researchers reports today in the Jan. 4 edition of the Journal of the American Medical Association.

• share
• favorite_border

By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the January issue of Nature Cell Biology.

• share
• favorite_border

A study of 781 clinical trial participants about factors associated with DNA methylation in healthy colorectal tissue ties red blood cell folate count to gene silencing.

• share
• favorite_border

The recently identified TRIM24 protein plays an active role in pushing normal breast cells into rapid cell proliferation and, potentially, into breast cancer.

• share
• favorite_border

MD Anderson encourages holiday partygoers to practice mindful behavior.

• share
• favorite_border

Metastatic breast cancer patients whose blood contains circulating tumor cells (CTCs) before or after treatment with high-dose chemotherapy and blood stem cell transplant have shorter survival periods, according to a new study by researchers at The University of Texas MD Anderson Cancer Center in Houston.

• share
• favorite_border

A two-drug combination is safe and active in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome patients who are usually excluded from clinical trials because they have other illnesses or poor performance status - a measure of disease progression - researchers reported this week at the 52nd American Society of Hematology Annual Meeting.

• share
• favorite_border

Behavioral scientist and tobacco-cessation expert, Alexander V. Prokhorov, M.D., Ph.D., at The University of Texas MD Anderson Cancer Center is the recipient of the 2011 American Society of Preventive Oncology (ASPO) Joseph W. Cullen Memorial Award for Excellence in Tobacco Research.

• share
• favorite_border

A pioneering clinical trial is testing the effectiveness in leukemia of a small molecule that shuts down MDM2, a protein that can disable the well-known tumor suppressor p53.

• share
• favorite_border

A new drug appears to help chronic myeloid leukemia patients who are out of treatment options after first- and second-line drugs have failed them or because their cancer cells have a mutation that makes them resistant from the start, researchers reported at the 52nd Annual Meeting of the American Society of Hematology.

• share
• favorite_border

A Conversation With a Living Legend® in Dallas, benefiting The University of Texas MD Anderson Cancer Center, showcases CBS chief Washington correspondent Bob Schieffer as its 21st annual honoree in an interview with NBC News special correspondent Tom Brokaw, 11:30 a.m. to 1:30 p.m. Dec. 13 in the Chantilly Ballroom of the Hilton Anatole, 2201 Stemmons Freeway.

• share
• favorite_border

Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.

• share
• favorite_border

MD Anderson’s exercise tips for the holidays.

• share
• favorite_border

A $16-million, five-year grant by the National Cancer Institute's nanomedicine initiative blends the expertise of five research institutions to focus an array of innovative nanotechnologies on improving the outcome of patients with ovarian or pancreatic cancers.

• share
• favorite_border

Phase I trial establishes dose, catalogues side effects, hints at targeted drug’s potential -- 38 percent have objective response, 25 percent have complete remission.

• share
• favorite_border

Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer.

• share
• favorite_border

Former President of Mexico Vicente Fox and retired CNN News Group chairman Tom Johnson take the stage Oct. 29 at the Grand Hyatt San Antonio for A Conversation With a Living Legend®. The inaugural luncheon fundraiser in San Antonio, featuring an exclusive onstage interview of Fox by Johnson, benefits the Blanton-Davis Ovarian Cancer Research Program at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Mothers who have children diagnosed with cancer now have a better approach to address and cope with stresses associated with their child's disease.

• share
• favorite_border

Long overshadowed by p53, its famous tumor-suppressing sibling, the p63 gene does the tougher, important job of stifling the spread of cancer to other organs, researchers at The University of Texas MD Anderson Cancer Center report in the Oct. 21 issue of Nature.